Ethical Issues of Predictive Genetic Testing for Diabetes
AUTOR(ES)
Haga, Susanne B.
FONTE
Diabetes Technology Society
RESUMO
With the rising number of individuals affected with diabetes and the significant health care costs of treatment, the emphasis on prevention is key to controlling the health burden of this disease. Several genetic and genomic studies have identified genetic variants associated with increased risk to diabetes. As a result, commercial testing is available to predict an individual's genetic risk. Although the clinical benefits of testing have not yet been demonstrated, it is worth considering some of the ethical implications of testing for this common chronic disease. In this article, I discuss several issues that should be considered during the translation of predictive testing for diabetes, including familial implications, improvement of risk communication, implications for behavioral change and health outcomes, the Genetic Information Nondiscrimination Act, direct-to-consumer testing, and appropriate age of testing.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2769962Documentos Relacionados
- Screening for fetal and genetic abnormality: social and ethical issues.
- Screening for fetal and genetic abnormality: social and ethical issues.
- Predictive genetic testing in children.
- Nuffield Council on Bioethics: Genetic Screening Ethical Issues
- Ethical issues policy statement on Huntington's disease molecular genetics predictive test. International Huntington Association. World Federation of Neurology.